Ambrisentan REMS Patient Survey

Ambrisentan REMS Survey for Patients

You are being asked to participate in a survey regarding the Ambrisentan REMS Program. This important survey is for patients who have received ambrisentan and are currently enrolled in the Ambrisentan REMS. Results from the survey remain confidential by BioTrak Research, Inc. This is a voluntary survey that is strictly confidential.

Participants who complete this 10-15 minute survey will be mailed a $40 Visa card for their time. All payments are processed within 4-6 weeks.

Important:
Please ensure that you can devote 15 minutes to complete this survey before beginning.
You cannot leave the survey and return to complete it at a later time. You may complete this survey one time only.

If you have a survey code, please click here.

To ensure your privacy:
  • Your healthcare provider will not be notified of your participation or your survey results.
  • Taking part in this survey will not effect on your ability to receive your medication.
  • The survey asks questions about the materials that you may have received with your medicine.
  • Your answers to the survey questions will be combined with answers given by others.

BioTrak Research reviews individual survey responses for the purposes of quality control and ethics of participation. If it is determined that any respondent has quickly “clicked through” the survey based upon survey times and responses, or an imposter has completed the survey, such survey completions may be disqualified and thusly not compensated at the sole discretion of BioTrak.

For questions or assistance please contact BioTrak Research Inc. at 877-248-8657 or ewelty@biotrak.com.